Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Omeprazole
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Omeprazole 40mg inj vials
0103050P0AABGBG
|
Omeprazole | Omeprazole | Gastro-Intestinal System | No data available |
|
Omeprazole 4mg/5ml oral liquid
0103050P0AAASAS
|
Omeprazole | Omeprazole | Gastro-Intestinal System | No data available |
|
Omeprazole 500micrograms/5ml oral liquid
0103050P0AAAYAY
|
Omeprazole | Omeprazole | Gastro-Intestinal System | No data available |
|
Omeprazole 6.8mg/5ml oral liquid
0103050P0AABKBK
|
Omeprazole | Omeprazole | Gastro-Intestinal System | No data available |
|
Omeprazole 7mg/5ml oral suspension
0103050P0AABQBQ
|
Omeprazole | Omeprazole | Gastro-Intestinal System | No data available |
|
Omeprazole 8.5mg/5ml oral liquid
0103050P0AABJBJ
|
Omeprazole | Omeprazole | Gastro-Intestinal System | No data available |
|
Omeprazole 8mg/5ml oral liquid
0103050P0AAAZAZ
|
Omeprazole | Omeprazole | Gastro-Intestinal System | No data available |
|
Omeran 10mg gastro-resistant tablets
0103050P0BDAABC
|
Omeran | Omeprazole | Gastro-Intestinal System | No data available |
|
Omeran 20mg gastro-resistant tablets
0103050P0BDABBD
|
Omeran | Omeprazole | Gastro-Intestinal System | No data available |
|
Omeran 40mg gastro-resistant tablets
0103050P0BDACBE
|
Omeran | Omeprazole | Gastro-Intestinal System | No data available |
|
Pyrocalm Control 20mg gastro-resistant tablets
0103050P0BHAABD
|
Pyrocalm Control | Omeprazole | Gastro-Intestinal System | No data available |
|
Zanprol 10mg gastro-resistant tablets
0103050P0BEAABC
|
Zanprol | Omeprazole | Gastro-Intestinal System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.